We have located links that may give you full text access.
COMMENT
EDITORIAL
Defining small vessels and bioresorbable vascular scaffold outcomes.
Catheterization and Cardiovascular Interventions 2016 September
Bioresorbable vascular scaffolds (BVS) are non-inferior to second generation drug eluting stents (DES) but thrombosis rates for BVS in small vesseles is a concern. The BVS-SAVE registry of small vesseles (<2.75 mm) supports safety and efficacy of BVS in this high risk lesion subset. Definitive recommendation for BVS in small vessels require further trials DES with evaluation of the lower threshold for minimal reference vesseles diameter.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app